Skip to main content
Premium Trial:

Request an Annual Quote

Merck Licenses Ingenuity Pathways Analysis Software

NEW YORK, Dec. 6 (GenomeWeb News) - Merck has taken a multi-year license to Ingenuity's Pathways Analysis software for use by its scientists worldwide, the companies said today.

 

Under the multi-year license, Merck plans to use the application, which contains information about biological networks and pathways curated from the scientific literature, together with its own tools for molecular profiling.

 

Merck will also integrate Ingenuity Pathways Analysis with its own bioinformatics systems.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.